Gastroenteropancreatic Neuroendocrine Tumors
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Gastroenteropancreatic Neuroendocrine Tumors
May 24, 2024, 01:22 |
Blog
Tanja Obradovic on Radiopharmaceuticals in oncology
Tanja Obradovic shared a post on LinkedIn: "Radiopharmaceuticals in oncology have been recently very active clinical…
May 23, 2024, 11:09 |
Blog
Jun Gong: The role of primary tumor resection in metastatic well-differentiated GETNET
Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared a…
May 7, 2024, 16:05 |
Insight
Neuroendocrine tumors - newly updated AJCC guidelines
Newly updated guidelines on neuroendocrine tumors developed by an expert at Sylvester Comprehensive Cancer Center…
May 2, 2024, 14:54 |
Insight
Mark Lewis: Version 9 of AJCC staging for GEP-NETs
Mark Lewis shared the following on X: “JUST RELEASED! Version 9 of American Joint Committee on…
Apr 30, 2024, 19:30 |
Blog
Nieves Martinez Lago: Critical updates in neuroendocrine tumors
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter: “Critical…
All:
5
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube